Reckitt Benckiser Group plc

Price Chart

Risk-Adjusted Performance

Also Listed On

Reckitt Benckiser Group plc (3RB) Price Performance

Reckitt Benckiser Group plc (3RB) trades on XETRA (Frankfurt) in EUR. The company is classified in the Consumer Defensive sector under the Household & Personal Products industry. The stock currently trades at EUR69.41, down 2.84% from the previous close.

Over the past year, 3RB has traded between a low of EUR53.19 and a high of EUR72.01. The stock has gained 16.2% over this period. It is currently 30.5% above its 52-week low.

Reckitt Benckiser Group plc has a market capitalization of $45.33B, with a price-to-earnings ratio of 31.81 and a dividend yield of 3.10%.

About Reckitt Benckiser Group plc

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol brands. In addition, the company offers nutritious complementary foods and milk formulas for infant and young children under the Enfamil and Nutramigen brands. Reckitt Benckiser Group plc was founded in 1819 and is headquartered in Slough, the United Kingdom.